Search results
How Jennifer Doudna's Life Has Changed Since Discovering CRISPR 10 Years Ago
Time via Yahoo News· 2 years agoDr. Jennifer Doudna in Berkeley, Calif., on Jan. 18, 2019. Credit - Anastasiia Sapon—The New York...
CRISPR 'will provide cures for genetic diseases that were incurable before,' says renowned...
Live Science via Yahoo News· 4 months agoVirginijus Šikšnys (an older man with short brown hair and round glasses wearing a suit jacket)...
CRISPR Therapeutics and Dollar General have been highlighted as Zacks Bull and Bear of the Day
Zacks via Yahoo Finance· 6 months agoFor Immediate Release Chicago, IL – December 11, 2023 – Zacks Equity Research shares CRISPR...
3 CRISPR Gene Editing Stocks to Consider for Ground-Floor Investing
InvestorPlace via Yahoo Finance· 1 year agoThe 2022 Nobel Prize in Chemistry went to Emmanuelle Charpentier and Jennifer Doudna for their work...
After a decade, CRISPR gene editing is a 'revolution in progress.' What does the future hold?
USA TODAY via Yahoo News· 1 year agoMedical innovations typically take 17 years from the time a lightbulb goes off in a scientist's head...
FDA Approves First CRISPR Treatment in U.S.
Time via Yahoo News· 6 months agoSickled blood cells forming clumps in a vessel Credit - Getty Images It was only 11 years ago that scientists Jennifer Doudna and Emmanuelle Charpentier...
Crispr Therapeutics, And CRISPR Gene-Editing, Face Their Make-Or-Break Moment
Investor's Business Daily· 8 months agoCrispr Therapeutics is facing its make-or-break moment as experts point to a pivotal decision in...
What's Next For Gene-Editing Darling Crispr After Its 'Historic' First-Ever Approval?
Investor's Business Daily· 6 months agoCrispr Therapeutics just executed on a moonshot goal as it recently won U.K. approval for the first...
Regeneron to collaborate on gene editing therapies with Doudna-founded Mammoth
Reuters via AOL· 1 month agoMammoth's CRISPR-based gene editing platform and Regeneron's delivery technologies will be used to...
Editas cashes in on CRISPR patent with Vertex deal
BioPharma Dive via Yahoo Finance· 6 months agoDive Brief: Days after winning U.S. approval of the first CRISPR gene-editing medicine, Vertex Pharmaceuticals is clearing up potential intellectual...